why choose us

First received: February 10, 2023

Clinical Trial: A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat

Study Status: Completed

Recruit Status: RECRUITING

Condition: Subcutaneous Fat

Study Type: INTERVENTIONAL


Official Title: A Randomized, Placebo-Controlled, Phase 2b Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat

Brief Summary: This is a randomized, placebo-controlled, Phase 2b study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing subcutaneous fat.

Read more